NDC 68071-2811-06 - Acyclovir
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-2811
- Requested NDC
- 68071-2811-06
- Package NDCs from labels
- 68071-2811-8, 68071-2811-6, 68071-2811-5, 68071-2811-3, 68071-2811-06
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2026-08-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Acyclovir Tablets, USP | NuCare Pharmaceuticals,Inc. | 2026-08-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2811-5 | Acyclovir | 25 in 1 BOTTLE | TABLET | 25 | 4 | |
| 68071-2811-6 | Acyclovir | 60 in 1 BOTTLE | TABLET | 60 | 4 | |
| 68071-2811-8 | Acyclovir | 15 in 1 BOTTLE | TABLET | 15 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2811 | ACYCLOVIR TABLET [NUCARE PHARMACEUTICALS,INC.] | 4 | Current NDC, Legacy NDC, 3 package rows | 20250101_e5e99a6b-79a6-7fdb-e053-2a95a90a8563.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACYCLOVIR | ACYCLOVIR | Bryant Ranch Prepack | e5356160-cb35-4ff6-91d5-2ade594e0279 | 2026-03-25 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Bryant Ranch Prepack | 69e5455e-d0be-4c2b-b9ab-458b5480ed57 | 2026-03-16 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 8fdabab2-bc93-48ab-9c13-d22ec90fdcfc | 2026-02-27 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Florida Pharmaceutical Products, LLC | 3df7fa38-a869-45fb-98a3-81c5a2527d62 | 2026-02-18 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Major Pharmaceuticals | 46150f19-ce5d-42a0-80a7-f96fda2b9879 | 2026-02-18 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals, Inc. | b6d69697-12bb-4548-a6c3-2463cbf54f8f | 2026-02-11 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | A-S Medication Solutions | 2e6a3667-af06-40de-80c0-8c4346e0671f | 2026-02-08 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Camber Pharmaceuticals, Inc. | 0910335b-6796-459f-b97e-d7ef5439a060 | 2026-02-02 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | Glenmark Pharmaceuticals Inc., USA | 149f4418-7668-4d34-a6f9-69bf3a9c5049 | 2026-01-28 | Warnings, Adverse reactions | X4HES1O11F |
| acyclovir | ACYCLOVIR | ANI Pharmaceuticals, Inc. | 8208711c-18ba-4615-b932-3c0bb7e6efae | 2026-01-23 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Actavis Pharma, Inc. | a4c1305c-f18c-4fb0-83d8-2822341f2dfa | 2026-01-21 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc | 75334fc5-d236-401a-875c-f4f9c7749c1a | 2026-01-19 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc | c11c1136-7421-48ff-86d2-39507e80a04c | 2026-01-15 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Preferred Pharmaceuticals Inc. | b1033fda-8242-4006-b1cd-23474d70671f | 2026-01-15 | Warnings, Adverse reactions | ANDA209366 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | AvPAK | 6e203fa9-ee97-1e08-8d6a-fb57cfa13e19 | 2026-01-08 | Warnings, Adverse reactions | 197313 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Cadila Pharmaceuticals Limited | dbaf4bf5-57e3-4770-a9b2-d47649e54c1b | 2026-01-02 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | Northwind Health Company, LLC | 5dcfd21c-43f0-469c-be70-a4e74e6ccf88 | 2026-01-01 | Warnings, Adverse reactions | 197311 X4HES1O11F |
| Acyclovir | ACYCLOVIR | Northwind Health Company, LLC | f6f56143-ea74-af87-e053-6394a90ae346 | 2026-01-01 | Warnings, Adverse reactions | 197313 X4HES1O11F |
| acyclovir | ACYCLOVIR | Northwind Health Company, LLC | ff9776b3-a248-e1ea-e053-6294a90aeb7b | 2026-01-01 | Warnings, Adverse reactions | X4HES1O11F |
| Acyclovir | ACYCLOVIR | YILING PHARMACEUTICAL, INC. | 67e7b340-0635-2595-e053-2a91aa0ad266 | 2025-12-30 | Warnings, Adverse reactions | 197313 X4HES1O11F |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.